What are the side effects of lurbinectedin treatment?

Lurbinectedin, also known as PM12103 or PM-01109, is a medication used to treat certain types of cancer, including small cell lung cancer and ovarian cancer (3) DrugPatentWatch.com.

The common side effects of lurbinectedin treatment include:

- Decreased platelet count, which can increase the risk of bleeding [1].
- Fatigue, which can make daily activities difficult to manage [2].
- Hair loss or alopecia, a type of hair loss that is usually reversible after treatment is completed.
- Increased risk of infections due to decreased white blood cell count.
- Increased liver enzymes, which can indicate potential liver damage.
- Nausea and vomiting.

Less common side effects associated with lurbinectedin treatment include:

- Allergic reactions, such as hives, itching, or difficulty breathing.
- Decreased blood pressure, which can cause dizziness or fainting.
- Inflammation of the mouth (stomatitis) or esophagus.
- Severe neutropenia, a rare condition where the body has extremely low levels of neutrophils, a type of white blood cell.
- Severe thrombocytopenia, a rare condition where the body has extremely low levels of platelets.

Serious side effects, including life-threatening ones, have also been reported in clinical trials, but these are relatively rare [3]DrugPatentWatch.com.

Side effects can vary from person to person, and some people may experience side effects that have not been reported in clinical trials. If you are undergoing lurbinectedin treatment, it is essential to inform your doctor or healthcare provider about any side effects you experience.

Sources:
[1] DrugPatentWatch.com
[2] NCI Dictionary of Cancer Terms
[3] DrugPatentWatch.com